Bristol-Myers Squibb
- A01 - Preparados estomatológicos
- BRISTACYCLINE capsule, hard 250 mg
- BRISTACYCLINE capsule, hard 500 mg
- A10 - Antidiabéticos
- METAGLIP tablet 250 mg+2.5 mg
- METAGLIP tablet 500 mg+2.5 mg
- METAGLIP tablet 500 mg+5 mg
- B01 - Agentes antitrombóticos
- COUMADIN powder for solution for injection 5 mg
- COUMADIN tablet 1 mg
- COUMADIN tablet 10 mg
- COUMADIN tablet 2 mg
- COUMADIN tablet 2.5 mg
- COUMADIN tablet 3 mg
- COUMADIN tablet 4 mg
- COUMADIN tablet 5 mg
- COUMADIN tablet 6 mg
- COUMADIN tablet 7.5 mg
- B03 - Preparados antianémicos
- RUBRAMIN solution for injection 1 000 µg/1 ml
- B05 - Sustitutos de sangre y soluciones para perfusión
- DEXTROSE POTASSIUM CHLORIDE solution for infusion 5%+0.075%
- DEXTROSE POTASSIUM CHLORIDE solution for infusion 5%+0.15%
- DEXTROSE POTASSIUM CHLORIDE solution for infusion 5%+0.224%
- DEXTROSE POTASSIUM CHLORIDE solution for infusion 5%+0.3%
- C09 - Agentes activos sobre el sistema renina-angiotensina
- MONOPRIL HCT tablet 10 mg+12.5 mg
- MONOPRIL HCT tablet 20 mg+12.5 mg
- C10 - Agentes modificadores de los lípidos
- PRAVIGARD PAC tablet 20 mg+325 mg
- PRAVIGARD PAC tablet 20 mg+81 mg
- PRAVIGARD PAC tablet 40 mg+325 mg
- PRAVIGARD PAC tablet 40 mg+81 mg
- PRAVIGARD PAC tablet 80 mg+325 mg
- PRAVIGARD PAC tablet 80 mg+81 mg
- G03 - Hormonas sexuales y moduladores del sistema genital
- ESTRACE tablet 0.5 mg
- ESTRACE tablet 1 mg
- ESTRACE tablet 2 mg
- J01 - Antibacterianos para uso sistémico
- AZACTAM powder for solution for injection 500 mg
- CEFZIL film-coated tablet 250 mg
- CEFZIL film-coated tablet 500 mg
- CEFZIL powder for oral suspension 125 mg/5 ml
- CEFZIL powder for oral suspension 250 mg/5 ml
- J05 - Antivirales de uso sistémico
- VIDEX gastro-resistant capsule, hard 125 mg
- VIDEX gastro-resistant capsule, hard 200 mg
- VIDEX gastro-resistant capsule, hard 250 mg
- VIDEX gastro-resistant capsule, hard 400 mg
- VIDEX powder for oral solution 2 g
- VIDEX powder for oral solution 4 g
- L01 - Antineoplásicos
- BICNU powder for solution for infusion 100 mg
- BLENOXANE powder for solution for injection 15 000 IU
- BLENOXANE powder for solution for injection 30 000 IU
- CYTOXAN tablet 25 mg
- CYTOXAN tablet 50 mg
- ETOPOPHOS PRESERVATIVE FREE concentrate for solution for infusion 100 mg
- LYOPHILIZED CYTOXAN powder for solution for injection 1 g
- LYOPHILIZED CYTOXAN powder for solution for injection 100 mg
- LYOPHILIZED CYTOXAN powder for solution for injection 2 g
- LYOPHILIZED CYTOXAN powder for solution for injection 200 mg
- LYOPHILIZED CYTOXAN powder for solution for injection 500 mg
- PARAPLATIN powder for solution for infusion 150 mg
- PARAPLATIN powder for solution for infusion 450 mg
- PARAPLATIN powder for solution for infusion 50 mg
- VEPESID concentrate for solution for infusion 20 mg/ml
- VUMON solution for infusion 50 mg/5 ml
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- ORENCIA PREFILLED SYRINGE solution for injection 125 mg/1 ml
- N04 - Antiparkinsonianos
- LODOSYN tablet 25 mg
- N05 - Psicolépticos
- BUSPAR tablet 10 mg
- BUSPAR tablet 15 mg
- BUSPAR tablet 30 mg
- BUSPAR tablet 5 mg
- PROLIXIN DECANOATE solution for injection 25 mg/ml
- V03 - Todos los demás preparados terapéuticos
- IFEX MESNEX KIT solution for injection 1 g+100 mg/ml
- IFEX MESNEX KIT solution for injection 3 g+100 mg/ml
- V08 - Medios de contraste
- DEFINITY solution for injection 6.52 mg/ml
- V09 - Radiofármacos para diagnóstico
- CARDIOLITE solution for injection
- MIRALUMA solution for injection
- NEUROLITE KIT powder and solvent for solution for injection 0.9 mg+1 ml
- XENON inhalation gas 10 mCi/dose
- XENON inhalation gas 20 mCi/dose